Switch to:
GuruFocus has detected 3 Warning Signs with Biomarin Pharmaceutical Inc $BMRN.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
Biomarin Pharmaceutical Inc (NAS:BMRN)
EV/Revenue
14.36 (As of Today)

EV/Revenue ratio is calculated as enterprise value divided by its revenue. As of today, Biomarin Pharmaceutical Inc's enterprise value is USD 14,998 Mil. Biomarin Pharmaceutical Inc's revenue for the trailing twelve months (TTM) ended in Sep. 2016 was USD 1,045 Mil. Therefore, Biomarin Pharmaceutical Inc's EV/Revenue ratio for today is 14.36.

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV/Revenue is a similar ratio to P/S Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today, Biomarin Pharmaceutical Inc's stock price is USD 89.29. Biomarin Pharmaceutical Inc's revenue per share for the trailing twelve months (TTM) ended in Sep. 2016 was USD 6.40. Therefore, Biomarin Pharmaceutical Inc's P/S Ratio for today is 13.94.


Definition

EV/Revenue is a similar ratio to P/S Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Biomarin Pharmaceutical Inc's EV/Revenue for today is calculated as:

EV/Revenue=Enterprise Value (Today)/Revenue (TTM)
=14997.542/1044.699
=14.36

Biomarin Pharmaceutical Inc's current Enterprise Value is USD 14,998 Mil.
Biomarin Pharmaceutical Inc's Revenue for the trailing twelve months (TTM) ended in Sep. 2016 was 227.936 (Dec. 2015 ) + 236.736 (Mar. 2016 ) + 300.131 (Jun. 2016 ) + 279.896 (Sep. 2016 ) = USD 1,045 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Biomarin Pharmaceutical Inc's P/S Ratio for today is calculated as:

P/S Ratio=Share Price (Today)/Revenue Per Share (TTM)
=89.29/6.404
=13.94

Biomarin Pharmaceutical Inc's share price for today is USD 89.29.
Biomarin Pharmaceutical Inc's Revenue Per Share for the trailing twelve months (TTM) ended in Sep. 2016 was 1.424 (Dec. 2015 ) + 1.465 (Mar. 2016 ) + 1.846 (Jun. 2016 ) + 1.669 (Sep. 2016 ) = USD 6.40.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Related Terms

Enterprise Value, Revenue, P/S Ratio


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

Biomarin Pharmaceutical Inc Annual Data

Dec06Dec07Dec08Dec09Dec10Dec11Dec12Dec13Dec14Dec15
ev2rev 17.1627.556.026.458.199.2912.1618.1517.5719.09

Biomarin Pharmaceutical Inc Quarterly Data

Jun14Sep14Dec14Mar15Jun15Sep15Dec15Mar16Jun16Sep16
ev2rev 14.2915.9417.5724.5525.5919.0819.0914.7213.2214.86
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK